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What is NaProTechnology?
NaProTechnology (NPT) is a medical and surgical approach to fertility 
care that works synergistically with a woman’s reproductive system. It 
does this by identifying the root of the problem and working to correct 
it in conjunction with the natural fertility cycle. NPT uses Fertility 
Awareness-Based Methods (FABMs), like the Creighton Model System 
(CrMS), to diagnose and treat chronic disorders related to infertility.  
What can it
v Infertility
vMenstrual Cramps
v Premenstrual 
Syndrome (PMS)
v Ovarian Cysts
v Irregular or Abnormal 
Bleeding
v Polycystic Ovarian 
Syndrome (PCOS)
v Repetitive Miscarriage
help with?
v Hormonal 
Abnormalities
v Chronic Discharges
v Prevention of Preterm 
Birth
v Tubal Occlusion
v Ectopic Pregnancy
v Endometriosis
v Postpartum 
Depression (PPD)
How does it do this?
NaProTechnology utilizes the CrMS cycle tracking 
system, individualized hormone assessment, 
ultrasound technology, selective 
hysterosalpingography, and diagnostic 
laparoscopy for the detection, diagnosis, and 
treatment of chronic reproductive conditions.  
NaProTracking
Figure 4 displays four abnormal menstrual cycles 
charted using the Creighton (CrMS) method, or 
“NaProTracking”, for women’s health.
v Cycle 1: a limited mucus cycle is seen by few 
white and green baby stickers, which often 
indicates infertility or miscarriage.
v Cycle 2: a short post-Peak phase is noted, 
meaning that there is an inadequate luteal 
phase. This is seen in repetitive miscarriage 
and is identified by an insufficient number of 
solid green stickers at the end of the cycle.
v Cycle 3: premenstrual spotting is recorded as 
three or more days of light (L), very light (VL), 
or brown (B) bleeding prior to menstruation. 
These are seen by red stickers at the end of the 
cycle and indicate low progesterone.
v Cycle 4: abnormal bleeding is observed as an 
unusually long menstrual phase, followed by 
spotting and no cervical mucus build-up. This 
is represented by randomized red, solid green, 
and white/green baby stickers and is indicative 
of a variety of gynecological health problems.
Maternal and Fetal Risks  
Natural Conception
v 23% high order multiples
v 7.9% preterm birth
v 4.9% low birth weight
v 0.4% monozygosity
v 0.02% congenital malformation
v 1.26% maternal morbidity
of Fertility Interventions 
Assisted Reproductive Technology 
v 32% high order multiples
v 9.7% preterm birth
v 6.8% low birth weight
v 1.3% monozygosity
v 0.15% congenital malformation
v 2.73% maternal morbidity
Figure 2: Pope Paul VI Institute for the Study of Human Reproduction. (2004). Effectiveness summary: natural procreative (NaPro) technology vs. artificial reproductive 
technologies [Table]. Retrieved from: https://www.popepaulvi.com/PDF/NaPro-vs-ART.pdf 
Holistic Health Impacts
Nursing Influence   
v Patient Education
v Individualized Care
v Engagement in 
Nursing Research
& Opportunities
v Professional 
Development
v CrMS Training
v Advanced Practice 
Consultation
Physical
↓ preterm birth
↓ multiples
↓ LBW
↓ congenital defects
Emotional
↑ stability in relationships
↓ stress
↑ marital satisfaction
Physical
↑ LBW
↑ multiples
↑ breast cancer
↑ miscarriage
↑ ulcerative colitis
Financial
Relational
Emotional Relational
Financial 
$322/cycle (NPT)
CrMS charting materials 
$10,500-$12,500/cycle (IVF)
Oral contraceptives
↓ stability in relationships
↑ anxiety
↑ depression 
↑ stress
↓ libido
S. P. I. C. E. 
Moral or ethical 
dilemmas 
NPT
ART
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